QUCY on Nasdaq

Quantum Cyber N.V.

Pharmaceutical preparations company based in Mainz, listed on Nasdaq (QUCY). Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with LIPELLA PHARMACEUTICALS INC., Silence Therapeutics plc or Trevena Inc, or pick any stock.

  • TickerQUCY on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersP71
  • Incorporated inNetherlands2
  • Business addressRobert Koch Strasse 50, Mainz2
  • Filer category, Emerging growth company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Quantum Cyber as a d/b/a until that time. In conjunction with the name change, we changed our Nasdaq ticker symbol to “QUCY”.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

72.6%Gross margin4
-3005.0%Operating margin4
-3018.3%Net margin4
-39.9%Revenue growth, 20254
-2526.6%Return on equity4
-$11.0MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue3¢$147.3K
  • Research and development97¢$4.9M

Out of $537.1K in revenue.4 The company lost money this year.

Financial statements

Revenue56784$537.1K in 2025+91% since 2019
0$250.0K$500.0K$750.0K$1.0M2019: $281.4K$281.4K20192020: $493.6K$493.6K2020+75%2021: $577.3K$577.3K2021+17%2022: $529.9K$529.9K2022−8%2023: $895.5K$895.5K2023+69%2024: $894.0K$894.0K2024−0%2025: $537.1K$537.1K2025−40%
Gross profit56784$389.8K in 2025
-$200.0K0$200.0K$400.0K$600.0K2019: -$61.3K-$61.3K20192020: $123.1K$123.1K20202021: $177.6K$177.6K2021+44%2022: $182.2K$182.2K2022+3%2023: $509.7K$509.7K2023+180%2024: $574.9K$574.9K2024+13%2025: $389.8K$389.8K2025−32%
Operating income56784-$16.1M in 2025+1651% since 2019
-$30.0M-$20.0M-$10.0M02019: -$921.9K-$921.9K20192020: -$673.7K-$673.7K2020−27%2021: -$9.7M-$9.7M2021+1343%2022: -$26.4M-$26.4M2022+172%2023: -$26.6M-$26.6M2023+1%2024: -$18.8M-$18.8M2024−30%2025: -$16.1M-$16.1M2025−14%
Net income56784-$16.2M in 2025+1594% since 2019
-$30.0M-$20.0M-$10.0M02019: -$957.1K-$957.1K20192020: -$586.9K-$586.9K2020−39%2021: -$11.7M-$11.7M2021+1892%2022: -$26.4M-$26.4M2022+126%2023: -$26.3M-$26.3M2023−0%2024: -$21.6M-$21.6M2024−18%2025: -$16.2M-$16.2M2025−25%

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Total revenue$537.1K$894.0K
Cost of revenue$147.3K$319.1K
Gross profit$389.8K$574.9K
Sales and marketing$3.8M$6.6M
Research and development$4.9M$5.7M
Research and development related party$54.8K$121.2K
General and administrative (Note 2)$5.1M$6.7M
Impairment of intangible asset$2.6M
Restructuring expense$277.2K
Total operating expenses$16.5M$19.3M
Loss from operations-$16.1M-$18.8M
Other income$42.2K$90.6K
Government grant$533.5K$46.1K
Gain on sale of subsidiary$28.3K
Change in fair value of convertible debt$21.0K-$2.1M
Gain (loss) on sales and disposal of assets-$163.2K$46.8K
Interest expense-$373.5K-$945.5K
Other expense-$131.6K-$39.8K
Total other expense-$71.6K-$2.8M
Loss before income tax-$16.2M-$21.6M
Net loss-$16.2M-$21.6M
Foreign currency translation adjustment-$69.0K-$96.3K
Total comprehensive loss-$16.3M-$21.7M
Basic loss per ordinary share (in Dollars per share)-$2.70-$21.91
Diluted loss per ordinary share (in Dollars per share)-$2.70-$21.91
Basic Weighted average number of ordinary shares outstanding (in Shares)6.0M shares985.7K shares
Diluted Weighted average number of ordinary shares outstanding (in Shares)6.0M shares985.7K shares

Compare Quantum Cyber N.V. with another company

Leadership

Who has led Quantum Cyber N.V., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Guido Baechler2026
  2. David E. Lazar2026–now

Chief financial officer

  1. William J. Caragol2026–now
Board members and other officers (9)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerDarin Leigh named May 10, 202422
  • Executive Officer, DirectorMoritz Eidens named May 10, 202422
  • Executive OfficerPhillip Freese named May 10, 202422
  • DirectorAlberto Libanori named May 10, 202422
  • DirectorGregory Tibbits named May 10, 202422
  • DirectorNicole Holden named May 10, 202422

Former names

  • MAINZ BIOMED N.V.Aug 25, 2021 to Apr 15, 20262
  • Mainz Biomed B.V.Aug 3, 2021 to Nov 12, 20212

Timeline

  1. Apr 28, 2026New chief executive David E. Lazar becomes CEO12
  2. Jan 26, 2026New chief executive Guido Baechler becomes CEO11

Filings

198 filings to the SEC since October 2021: 5 annual reports, 2 quarterly reports, 22 major events, 35 insider forms, 14 large holders, 2 private raises, 118 other. The latest 20:

  1. Oct 9, 20268-K CURRENT REPORT EDGAR
  2. Oct 9, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
  3. Sep 25, 20268-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
  4. Sep 25, 20268-K CURRENT REPORT EDGAR
  5. Aug 14, 202610-Q QUARTERLY REPORT EDGAR
  6. Aug 12, 20264 EDGAR
  7. Aug 10, 2026SCHEDULE 13G EDGAR
  8. Aug 7, 20264 EDGAR
  9. Aug 7, 2026SCHEDULE 13D/A EDGAR
  10. Aug 6, 20264/A EDGAR
  11. Aug 6, 20264/A EDGAR
  12. Aug 6, 20264/A EDGAR
  13. Aug 6, 20264/A EDGAR
  14. Aug 6, 20264/A EDGAR
  15. Aug 5, 20264 EDGAR
  16. Aug 4, 20264 EDGAR
  17. Aug 4, 20264 EDGAR
  18. Aug 4, 20264 EDGAR
  19. Aug 4, 20264 EDGAR
  20. Jul 24, 20268-K CURRENT REPORT EDGAR

The 198 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 2 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Oct 17, 2025Donahue Kevin Michael10% ownerBuy685,000$1.51$1.0MForm 4
Oct 17, 2025Donahue Kevin Michael10% ownerBuy643,850$402,000.00$258.8BForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • BP United Inc.SCHEDULE 13G, 1 filing Aug 10, 202623
  • David E. LazarSCHEDULE 13D/A, 2 filings Apr 28, 2026 to Aug 7, 202624
  • ARMISTICE CAPITAL, LLCSCHEDULE 13G/A, 4 filings Feb 14, 2025 to Feb 17, 202625
  • Kevin Michael DonahueSCHEDULE 13G/A, 2 filings Jan 16, 2026 to Jan 20, 202626
  • KfWSC 13G/A, 3 filings Mar 1, 2023 to Oct 7, 202427
  • Hans HeklandSC 13G, 1 filing May 16, 202228
  • Moritz EidensSC 13G, 1 filing May 16, 202229

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jun 28, 2023Raised $14.3 million in a private offering of securities Form D: $50 million offered in all Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29